Clinical Trials Browser

Phase 1 × MVAp53 vaccine × Gynecologic × Clear all

NCT02275039 2018-04-30

p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer

Phase 1 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms